Abstract:Objective: Because histologic features can be unreliable in determining the malignant potential of pancreatic endocrine neoplasms (PENS), we characterized the methylation patterns of PENs to develop a molecular marker system useful for clinical prognosis.Summary Background Data: Aberrant promoter methylation of tumor suppressor genes is associated with a loss of gene function that can afford selective growth advantages to neoplastic cells. Gene hypetmethylation, coupled with sporadic genetic mutations, defines the heterogeneous biology of human neoplasms.Methods: Forty-eight well-differentiated PENS were subjected to methylation-specific polymerase chain reaction to detect aberrant methylation associated with l l candidate tumor suppressor genes (INK4a/p16, APC, O-6-MGMT, hMLH1, p73, E-cadherin, RAR-beta, p14ARF, GST-pi, TIMP3, and RASSF1A). Methylation differences among PENS, subdivided according to tumor size, lymph node status, or liver metastasis, were analyzed, and the association of gene methylation with tumor recurrence and patient survival was evaluated.Results: Aberrant hypermethylation of any of the 11 tumor suppressor genes was detected in 87% of the PENS. In decreasing order of frequency, the 5 most commonly methylated genes were: RASSF1A (75%), fNK4a/p16 (40%), O-6-MGMT (40%), RAR-beta (25%), and hMLH1 (23%). In general, tumors larger than 5 cm and those associated with lymph node or hepatic metastases exhibited a higher frequency of methylation at each promoter site compared with PENS without malignant histologic features. The methylation of specific tumor suppressor genes was an independent predictor of early PEN recurrence and decreased 5-year survival following surgical resection. The accumulation of methylation of multiple tumor suppressor genes was associated with early tumor recurrence and reduced survival among a subpopulation of patients with lymph node-negative PENS.Conclusions: Aberrant methylation of multiple tumor suppressor genes is associated with advanced tumor stage and identifies molecularly distinct PENS with identical histologic characteristics. The methylation status of specific tumor suppressor genes is predictive of PEN behavior.

Aberrant Methylation in CpG Islands of P15 and P16 Tumor Suppressor Genes in Pancreatic Cancer Tissue

Detection of aberrant methylation of RARβ2, GSTP1 and DAPK gene in prostate cancer and its clinical significance

Association of Low P16ink4a and P15ink4b Mrnas Expression with Their Cpg Islands Methylation with Human Hepatocellular Carcinogenesis

Aberrant Methylation of CpG Island in 5'promoter Region of P16 Gene and Its Role in Diagnosis of Pancreatic Cancer

High-frequency aberrantly methylated targets in pancreatic adenocarcinoma identified via global DNA methylation analysis using methylCap-seq

Analysis of aberrant methylation of p16 gene promoter in tissue from gastric cancer patients

Methylation of P16 CpG Islands Correlated with Malignant Progression of Gastric Dysplasia in a Nested Case-Control Study

Methylation Of P16 Cpg Islands Associated With Malignant Transformation Of Gastric Dysplasia In A Population-Based Study

Aberrant Hypermethylation of Tumor Suppressor Genes in Pancreatic Endocrine Neoplasms

The Exon 1 CpG Island of the Tumor Suppressor P16 Gene Aberrant Methylation in Cervical Carcinogenesis

Hypermethylation of CpG island at p16 gene promoter in gastric carcinomas

Methylation of CpG Islands of P16 Associated with Progression of Primary Gastric Carcinomas

Clinical Significance of Tumor Suppressor Genes Methylation in Circulating Tumor DNA of Patients with Pancreatic Cancer

P16 CpG Region Methylation of the Colorectal Cancer and Its Association with Clinicopathological Characteristics

Methylation Status of P16 Gene in Colorectal Carcinoma and Normal Colonic Mucosa.

Relationship Between the Aberrant Methylation of CpG Island of TFPI-2 Gene and Pancreatic Cancer

Investigation of Aberrantly Methylated Differentially Expressed Genes in Pancreatic Cancer by Integrated Bioinformatics Analysis

P16 Gene Methylation in Colorectal Cancers Associated with Duke's Staging.

Methylation and Aberrant Expression of the p16 Gene in Cervical Carcinoma

Study of P16 Tumor Suppressor Gene with Methylation-Specific PCR